These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 36036898

  • 1. Sequential Nano-Penetrators of Capillarized Liver Sinusoids and Extracellular Matrix Barriers for Liver Fibrosis Therapy.
    Zhang LF, Wang XH, Zhang CL, Lee J, Duan BW, Xing L, Li L, Oh YK, Jiang HL.
    ACS Nano; 2022 Sep 27; 16(9):14029-14042. PubMed ID: 36036898
    [Abstract] [Full Text] [Related]

  • 2. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.
    Wang X, Zhang W, Zeng S, Wang L, Wang B.
    Acta Biomater; 2024 Feb 27; 175():262-278. PubMed ID: 38141933
    [Abstract] [Full Text] [Related]

  • 3. Neutrophil-Based Bionic Delivery System Breaks Through the Capillary Barrier of Liver Sinusoidal Endothelial Cells and Inhibits the Activation of Hepatic Stellate Cells.
    Sun D, Du X, Cao X, Wu B, Li S, Zhao Y, Liu T, Xu L, Huang H.
    Mol Pharm; 2024 Apr 01; 21(4):2043-2057. PubMed ID: 38471114
    [Abstract] [Full Text] [Related]

  • 4. Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis.
    Wang K, Chen H, Zheng J, Chen J, Chen Y, Yuan Y.
    J Control Release; 2024 Apr 01; 368():219-232. PubMed ID: 38367862
    [Abstract] [Full Text] [Related]

  • 5. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
    Zhou L, Liang Q, Li Y, Cao Y, Li J, Yang J, Liu J, Bi J, Liu Y.
    Acta Biomater; 2022 Oct 15; 152():235-254. PubMed ID: 36087869
    [Abstract] [Full Text] [Related]

  • 6. Restoration of Sinusoid Fenestrae Followed by Targeted Nanoassembly Delivery of an Anti-Fibrotic Agent Improves Treatment Efficacy in Liver Fibrosis.
    Li F, Zhao Y, Cheng Z, Wang Y, Yue Y, Cheng X, Sun J, Atabakhshi-Kashi M, Yao J, Dou J, Yu J, Zhang X, Qi Y, Li X, Qi X, Nie G.
    Adv Mater; 2023 Apr 15; 35(17):e2212206. PubMed ID: 36862807
    [Abstract] [Full Text] [Related]

  • 7. Capillarized Liver Sinusoidal Endothelial Cells Undergo Partial Endothelial-Mesenchymal Transition to Actively Deposit Sinusoidal ECM in Liver Fibrosis.
    Ruan B, Duan JL, Xu H, Tao KS, Han H, Dou GR, Wang L.
    Front Cell Dev Biol; 2021 Apr 15; 9():671081. PubMed ID: 34277612
    [Abstract] [Full Text] [Related]

  • 8. Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy.
    Fan QQ, Zhang CL, Qiao JB, Cui PF, Xing L, Oh YK, Jiang HL.
    Biomaterials; 2020 Feb 15; 230():119616. PubMed ID: 31837823
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Delta-like ligand 4/DLL4 regulates the capillarization of liver sinusoidal endothelial cell and liver fibrogenesis.
    Chen L, Gu T, Li B, Li F, Ma Z, Zhang Q, Cai X, Lu L.
    Biochim Biophys Acta Mol Cell Res; 2019 Oct 15; 1866(10):1663-1675. PubMed ID: 31233801
    [Abstract] [Full Text] [Related]

  • 11. Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis.
    Guo Q, Furuta K, Islam S, Caporarello N, Kostallari E, Dielis K, Tschumperlin DJ, Hirsova P, Ibrahim SH.
    Front Immunol; 2022 Oct 15; 13():983255. PubMed ID: 36091042
    [Abstract] [Full Text] [Related]

  • 12. Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma.
    Yu Z, Guo J, Liu Y, Wang M, Liu Z, Gao Y, Huang L.
    J Nanobiotechnology; 2022 Jan 04; 20(1):9. PubMed ID: 34983554
    [Abstract] [Full Text] [Related]

  • 13. Sequential system based on ferritin delivery system and cell therapy for modulating the pathological microenvironment and promoting recovery.
    Xu L, Yang J, Cao X, Chen J, Liu Z, Cai L, Yu Y, Huang H.
    Int J Pharm; 2024 Oct 25; 664():124607. PubMed ID: 39159856
    [Abstract] [Full Text] [Related]

  • 14. Liver X receptor α is essential for the capillarization of liver sinusoidal endothelial cells in liver injury.
    Xing Y, Zhao T, Gao X, Wu Y.
    Sci Rep; 2016 Feb 18; 6():21309. PubMed ID: 26887957
    [Abstract] [Full Text] [Related]

  • 15. [Dynamic observation on capillarization of liver sinusoidal endothelial cells induced by Echinococcus multilocularis infection].
    Zhang R, Xie J, Wei F, Mo X, Song P, Cai Y, Lu Y, Sun J, Zhou Y, Lin L, Zhang T, Chen M.
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Apr 01; 36(1):34-43. PubMed ID: 38604683
    [Abstract] [Full Text] [Related]

  • 16. JAM-A is a multifaceted regulator in hepatic fibrogenesis, supporting LSEC integrity and stellate cell quiescence.
    Brozat JF, Brandt EF, Stark M, Fischer P, Wirtz TH, Flaßhove A, Rodenhausen AN, Vajen T, Heinzmann ACA, Schmitz SM, Abu Jhaisha S, Röth AA, Koenen RR, Sahin H, Trautwein C, Berres ML.
    Liver Int; 2022 May 01; 42(5):1185-1203. PubMed ID: 35129269
    [Abstract] [Full Text] [Related]

  • 17. Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling.
    Winkler M, Staniczek T, Kürschner SW, Schmid CD, Schönhaber H, Cordero J, Kessler L, Mathes A, Sticht C, Neßling M, Uvarovskii A, Anders S, Zhang XJ, von Figura G, Hartmann D, Mogler C, Dobreva G, Schledzewski K, Géraud C, Koch PS, Goerdt S.
    J Hepatol; 2021 Feb 01; 74(2):380-393. PubMed ID: 32916216
    [Abstract] [Full Text] [Related]

  • 18. Synergetic regulation of kupffer cells, extracellular matrix and hepatic stellate cells with versatile CXCR4-inhibiting nanocomplex for magnified therapy in liver fibrosis.
    Wu P, Luo X, Sun M, Sun B, Sun M.
    Biomaterials; 2022 May 01; 284():121492. PubMed ID: 35395456
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis.
    Qu J, Wang L, Li Y, Li X.
    Clin Mol Hepatol; 2024 Jul 01; 30(3):303-325. PubMed ID: 38414375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.